Help Avoid Interruptions in Opioid Use Disorder Treatment

October 2020

You're on the front lines to help patients overcome obstacles to getting meds for opioid use disorder (Suboxone, etc) during COVID-19.

About 1 in 3 patients with opioid use disorder (OUD) report changes or disruptions in care during the pandemic...such as trouble getting treatment with buprenorphine/naloxone, methadone, or naltrexone.

This is a big deal...barriers to care, isolation, and stress can lead to relapse.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Contraceptives Look Out for Oral Contraceptives With Similar Names or Packaging
Immunizations Listen for Questions About Vaccinations During COVID-19
Supplements Stay Alert for Patients Getting Risky Supplements Promoted for COVID-19
Influenza Prevent Issues With Antiviral Meds for Flu
Practice Watch for Patients Who Need a Viral Test for COVID-19
Immunizations Streamline Processes for Childhood Vaccinations
Substance Use Disorder Help Avoid Interruptions in Opioid Use Disorder Treatment
Med Safety Keep Skin Cancer Risk With Hydrochlorothiazide in Perspective
Alzheimer's Disease Double-Check Which Alzheimer's Med You're Dispensing

Help Avoid Interruptions in Opioid Use Disorder Treatment

Practical advice for a better career, with unlimited access to CE

Table of Contents